The global gastrointestinal cancer drugs market is a rapidly evolving segment within the oncology therapeutics industry, driven by the rising prevalence of cancers affecting the digestive system, including colorectal, gastric, liver, and pancreatic cancers. Increasing awareness about early diagnosis, advancements in treatment modalities, and the growing adoption of targeted therapies are...